Clock drawing in Alzheimer's disease. A novel measure of dementia severity.
about
Vitamin E for Alzheimer's dementia and mild cognitive impairmentCholinesterase inhibitors for deliriumA review of screening tests for cognitive impairmentValidity of the Clock Drawing Test in predicting reports of driving problems in the elderlyParkinson's Disease and Cognitive ImpairmentExplicit (semantic) memory for music in patients with mild cognitive impairment and early-stage Alzheimer's disease.Randomized trial on the effects of a combined physical/cognitive training in aged MCI subjects: the Train the Brain studyControlling memory impairment in elderly adults using virtual reality memory training: a randomized controlled pilot study.Neuropsychologic assessment in collaborative Parkinson's disease research: a proposal from the National Institute of Neurological Disorders and Stroke Morris K. Udall Centers of Excellence for Parkinson's Disease Research at the University of PennsyThe Framingham Heart Study clock drawing performance: normative data from the offspring cohort.Recruitment methods in Alzheimer's disease research: general practice versus population based screening by mail.The clock drawing test as a screening tool in mild cognitive impairment and very mild dementia: a new brief method of scoring and normative data in the elderly.Preliminary assessment of cognitive function in breast cancer patients treated with tamoxifen.Patients presenting to the emergency department with non-specific complaints: the Basel Non-specific Complaints (BANC) study.Does the Clock Drawing Test have focal neuroanatomical correlates?GP-support by means of AGnES-practice assistants and the use of telecare devices in a sparsely populated region in Northern Germany--proof of concept.Cognitive changes in alcohol-induced psychotic disorder.Longitudinal changes in clock drawing test (CDT) performance before and after cognitive declineMotor phenotype of decline in cognitive performance among community-dwellers without dementia: population-based study and meta-analysisPrevalence of dementia in an elderly rural population: effects of age, sex, and education.Cognitive function in elderly marathon runners: cross-sectional data from the marathon trial (APSOEM).Initial evaluation of suspected dementia. Asking the right questions.North of England evidence based guidelines development project: guideline for the primary care management of dementiaComparison of the diagnostic accuracy of neuropsychological tests in differentiating Alzheimer's disease from mild cognitive impairment: can the montreal cognitive assessment be better than the cambridge cognitive examination?Detection of dementia in primary care: comparison of the original and a modified Mini-Cog Assessment with the Mini-Mental State Examination.Co-morbidity and drug treatment in Alzheimer's disease. A cross sectional study of participants in the dementia study in northern Norway.Normative performance on the executive clock drawing task in a multi-ethnic bilingual cohort: a project FRONTIER studyClock drawing test ratings by dementia specialists: interrater reliability and diagnostic accuracy.The value of clock drawing in identifying executive cognitive dysfunction in people with a normal Mini-Mental State Examination score.The influence of fear of falling on gait variability: results from a large elderly population-based cross-sectional study.Gerstmann-Sträussler-Scheinker syndrome with the P102L pathogenic mutation presenting as familial Creutzfeldt-Jakob disease: a case report and review of the literature.Exercise rehabilitation on home-dwelling patients with Alzheimer's disease--a randomized, controlled trial. Study protocolThe effect of stimulation therapy and donepezil on cognitive function in Alzheimer's disease. A community based RCT with a two-by-two factorial design.Differences and the relationship in default mode network intrinsic activity and functional connectivity in mild Alzheimer's disease and amnestic mild cognitive impairmentMemory and Executive Screening (MES): a brief cognitive test for detecting mild cognitive impairment.Vitamin E for Alzheimer's dementia and mild cognitive impairment.Longitudinal changes in cognition in Parkinson's disease with and without dementia.Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial.Drawing clocks and driving cars.Visuospatial function in early Alzheimer's disease--the use of the Visual Object and Space Perception (VOSP) battery
P2860
Q24202844-E78E18CA-DFD8-4647-A1BB-39399013F725Q24242314-2F86C619-4574-4A71-B458-FFB926670E6EQ24678263-9720F2AC-AD2C-41E4-AD47-F0743A806315Q24797319-8B33C569-153A-4271-B9F8-1A2477E536F4Q30239814-B25EE938-7102-41C9-9E87-8F624B4BADA2Q30354860-00580AF2-D165-4331-AB40-07B03B88A79DQ30366283-233C810F-A578-4640-B0CB-9A0926E97477Q30382792-82795F89-2996-45F0-B451-E73E8DCDCF27Q30538175-C1EF3696-C34D-48C5-A8DB-D3FD24E337B7Q30585963-5C6AC321-5000-47A2-99AD-0A3C5A119C9DQ30982180-73FEF055-4432-45B2-8729-7B3F89274B46Q31044129-E73B9D44-8214-4A46-8D42-A7EF8279F427Q31979952-4016ED58-9A31-403A-8EF8-2E532C127D16Q33158613-7F8A989C-E2C6-4A8C-A85B-BB95D4358FB9Q33365665-F4DA2805-5A96-40E3-B28D-8E0D555A9EC4Q33471769-7D88106C-6073-4DCE-90D1-CB325E5F5FEDQ33608608-11D7DDFC-B573-4778-8C5E-2F7BCD642186Q33686210-478FCFC2-1E11-491A-A05F-7F3317CBD5EFQ33728055-7452618D-085D-441B-AD0A-5F707A9D99B8Q33735314-BADD36CD-BBBE-4886-9F37-5AFDCB3F673FQ33745364-466DAFB0-3D9B-4E94-A926-C7D41235D0CFQ33772806-88299ADA-E2C8-4211-9949-363EEE68249EQ33791951-5275536E-BCC3-45CB-8D1C-76B3AFAF717CQ33795233-CF843C6F-D6BE-4246-9E8D-50E44CA2EECCQ33866147-6DDDEF7C-F9D1-4A94-8E80-8C2BFC28E6DBQ34039605-25A1D7E8-5914-4C1E-813B-2166782E5744Q34080750-4AC238DB-E497-4330-A4CF-5DEF59E9E0DEQ34124716-95E9C23D-2950-4A12-96D2-66940232C368Q34133658-FA3BE000-83CB-427F-ABB0-AB9C9706DEC5Q34143780-673A1564-0F0A-4216-9CAA-D0EF8C8C3F14Q34228771-58EE3E49-E66F-461E-B550-EDA78A3DBFB1Q34297506-9CEF367E-0BD2-4071-902B-A83E84CE1772Q34343927-7DF07F19-D140-4F2E-ADBA-9F6D9DCF67ECQ34370410-61E7AA76-9042-4F4B-BC69-060D4EE6BFA2Q34439068-47C6E6FB-B875-4E6F-A662-AA2F72253FC8Q34550138-7511A23D-D53C-4199-900E-14B8B5396816Q34619632-AC3E0594-F4AA-4467-8A11-488B51F149C6Q34625666-2BA5C2E9-0205-4473-9071-974F9BFA5736Q34722835-557109B8-8AE5-4971-984F-EDD0B4EC88DFQ34848342-C63ADBC0-E139-467B-92A4-A1E27E5938C6
P2860
Clock drawing in Alzheimer's disease. A novel measure of dementia severity.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh-hant
name
Clock drawing in Alzheimer's disease. A novel measure of dementia severity.
@en
Clock drawing in Alzheimer's disease. A novel measure of dementia severity.
@nl
type
label
Clock drawing in Alzheimer's disease. A novel measure of dementia severity.
@en
Clock drawing in Alzheimer's disease. A novel measure of dementia severity.
@nl
prefLabel
Clock drawing in Alzheimer's disease. A novel measure of dementia severity.
@en
Clock drawing in Alzheimer's disease. A novel measure of dementia severity.
@nl
P2093
P2860
P1476
Clock drawing in Alzheimer's disease. A novel measure of dementia severity.
@en
P2093
Gundersheimer J
Newhouse PA
Sunderland T
P2860
P304
P356
10.1111/J.1532-5415.1989.TB02233.X
P407
P577
1989-08-01T00:00:00Z